Sienna Cancer Diagnostics Ltd logo

Sienna Cancer Diagnostics Ltd

2 Marks
Public Company Lim…
First Filed:Nov 8, 2019Latest Filed:Nov 8, 2019Address:C/- BARD1 Life Sciences Ltd,, AU

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
2(100%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

2 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
EXO-NET
EXO-NET
Trademark
Word
REGISTERED
Owner:
Serial:79274531
Filed:Nov 8, 2019
Classes:5
Registration:6248000
Registered:Jan 19, 2021
Goods & Services
Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of exosomes and other extra cellular vesicles for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying exosomes and other extra cellular vesicles for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying exosomes and other extra cellular vesicles that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying exosomes and other extra cellular vesicles that contain nucleic acid; antibodies that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; antibody fragments that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; antibody conjugates that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use
SIEN-NET
SIEN-NET
Trademark
Word
REGISTERED
Owner:
Serial:79274546
Filed:Nov 8, 2019
Classes:5
Registration:6248001
Registered:Jan 19, 2021
Goods & Services
Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of specific biological markers for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying specific biological markers for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying specific biological markers that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying specific biological markers that contain nucleic acid; antibodies that are specifically able to bind and capture specific biological markers for medical purposes; antibody fragments that are specifically able to bind and capture specific biological markers for medical purposes; antibody conjugates that are specifically able to bind and capture specific biological markers for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use